Molecular host-pathogen interaction in brucellosis: Current understanding and future approaches to vaccine development for mice and humans

Clinical Microbiology Reviews

Volumn 16, Issue 1, 2003, Pages 65-78

  Ko, Jinkyung ^a   Splitter, Gary A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUCELLA VACCINE; DNA VACCINE; INACTIVATED VACCINE; LIVE VACCINE; VIRULENCE FACTOR;

ABORTION; AGRICULTURE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CATTLE; DNA MICROARRAY; DRUG EFFICACY; DRUG SAFETY; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; GENETIC SCREENING; GOAT; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; MOUSE; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; PHAGOSOME; PROPHYLAXIS; PROTEOMICS; REVIEW; SHEEP; VACCINATION; ZOONOSIS;

ANIMALS; BRUCELLA; BRUCELLA VACCINE; BRUCELLOSIS; CATTLE; CATTLE DISEASES; MICE;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS BIOVAR ABORTUS; CAPRA HIRCUS; NEGIBACTERIA; OVIS ARIES;

EID: 0037237662     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.16.1.65-78.2003     Document Type: Review

References (173)

1. Ahmed, K., K. A. Al-Matrouk, G. Martinez, K. Oishi, V. O. Rotimi, and T. Nagatake. 1999. Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. Am. J. Trop. Med. Hyg. 61:425-427.
2. Allen, C. A., L. G. Adams, and T. A. Ficht. 1998. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect. Immun. 66:1008-1016.
3. Al-Mariri, A., A. Tibor, P. Mertens, X. De Bolle, P. Michel, J. Godefroid, K. Walravens, and J. J. Letesson. 2001. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect. Immun. 69:4816-4822.
4. Anderson, L., and J. Seilhamer. 1997. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537.
5. Anderson, T. D., and N. F. Cheville. 1986. Ultrastructural morphometric analysis of Brucella abortus-infected trophoblasts in experimental placentitis. Bacterial replication occurs in rough endoplasmic reticulum. Am. J. Pathol. 124:226-237.
6. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337.
7. Arenas, G. N., A. S. Staskevich, A. Aballay, and L. S. Mayorga. 2000. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect. Immun. 68:4255-4263.
8. Baldi, P. C., M. M. Wanke, M. E. Loza, N. Monachesi, and C. A. Fossati. 1997. Diagnosis of canine brucellosis by detection of serum antibodies against an 18 kDa cytoplasmic protein of Brucella spp. Vet. Microbiol. 57:273-281.
9. Baldwin, C. L., X. Jiang, and D. M. Fernandes. 1993. Macrophage control of Brucella abortus: influence of cytokines and iron. Trends Microbiol. 1:99-104.
10. Baldwin, C. L., and A. J. Winter. 1994. Macrophages and Brucella. Immunol. Ser. 60:363-380.
11. Barthel, R., J. Feng, J. A. Piedrahita, D. N. McMurray, J. W. Templeton, and L. G. Adams. 2001. Stable transfection of the bovine NRAMP1 gene into murine RAW264.7 cells: effect on Brucella abortus survival. Infect. Immun. 69:3110-3119.
12. Bellamy, R. 1999. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect. 1:23-27.
13. Bertotto, A., R. Gerli, F. Spinozzi, C. Muscat, F. Scalise, G. Castellucci, M. Sposito, F. Candio, and R. Vaccaro. 1993. Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur. J. Immunol. 23:1177-1180.
14. Blasco, J. M. 1997. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev. Vet. Med. 31:275-283.
15. Blasco, J. M., C. Marin, M. P. Jimenez de Bagues, and M. Barberan. 1993. Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams. Vaccine 11:1291-1294.
16. Boschiroli, M. L., V. Foulongne, and D. O'Callaghan. 2001. Brucellosis: a worldwide zoonosis. Curr. Opin. Microbiol. 4:58-64.
17. Bosseray, N. 1991. Brucella melitensis Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice. Biologicals 19:355-363.
18. Bowden, R. A., A. Cloeckaert, M. S. Zygmunt, and G. Dubray. 1998. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli. J. Med. Microbiol. 47:39-48.
19. Breedveld, M. W., and K. J. Miller. 1994. Cyclic beta-glucans of members of the family Rhizobiaceae. Microbiol. Rev. 58:145-161.
20. Bricker, B. J., L. B. Tabatabai, B. L. Deyoe, and J. E. Mayfield. 1988. Conservation of antigenicity in a 31-kDa Brucella protein. Vet. Microbiol. 18:313-325.
21. Bricker, B. J., L. B. Tabatabai, B. A. Judge, B. L. Deyoe, and J. E. Mayfield. 1990. Cloning, expression, and occurrence of the Brucella Cu-Zn superoxide dismutase. Infect. Immun. 58:2935-2939.
22. Brinley Morgan, W. J., and M. J. Corbel. 1990. Brucella infections in man and animals: contagious equine metritis, p. 547-570. In M. T. Parker and L. H. Collier (ed.), Topley and Wilson's principles of bacteriology, virology and immunology, 8th ed. Edward Arnold, London, England.
23. Briones, G., N. Inon de Iannino, M. Roset, A. Vigliocco, P. S. Paulo, and R. A. Ugalde. 2001. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect. Immun. 69:4528-4535.
24. Briones, G., N. Inon de Iannino, M. Steinberg, and R. A. Ugalde. 1997. Periplasmic cyclic 1,2-beta-glucan in Brucella spp. is not osmoregulated. Microbiology 143:1115-1124.
25. Brooks-Worrell, B. M., and G. A. Splitter. 1992. Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one-and two-dimensional cellular immunoblotting. Infect. Immun. 60:2459-2464.
26. Canning, P. C., J. A. Roth, and B. L. Deyoe. 1986. Release of 5′-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J. Infect. Dis. 154:464-470.
27. Canning, P. C., J. A. Roth, L. B. Tabatabai, and B. L. Deyoe. 1985. Isolation of components of Brucella abortus responsible for inhibition of function in bovine neutrophils. J. Infect. Dis. 152:913-921.
28. Caron, E., A. Gross, J. P. Liautard, and J. Dornand. 1996. Brucella species release a specific, protease-sensitive, inhibitor of TNF-α expression, active on human macrophage-like cells. J. Immunol. 156:2885-2893.
29. Celis, J. E., M. Kruhoffer, I. Gromova, C. Frederiksen, M. Ostergaard, T. Thykjaer, P. Gromov, J. Yu, H. Palsdottir, N. Magnusson, et al. 2000. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS. Lett. 480:2-16.
30. Cespedes, S., E. Andrews, H. Folch, and A. Onate. 2000. Identification and partial characterisation of a new protective antigen of Brucella abortus. J. Med. Microbiol. 49:165-170.
31. Chevalier, P., E. Bonnefoy, G. Kirkorian, and P. Touboul. 1996. Brucella pancarditis with fatal outcome. Presse Med. 25:628-630.
32. Cheville, N. F., R. A. Kunkle, A. E. Jensen, and M. V. Palmer. 1995. Persistence of Burcella abortus in the livers of T cell-deficient nude mice. Lab. Investig. 73:96-102.
33. Cheville, N. F., S. C. Olsen, A. E. Jensen, M. G. Stevens, A. M. Florance, H. S. Houng, E. S. Drazek, R. L. Warren, T. L. Hadfield, and D. L. Hoover. 1996. Bacterial persistence and immunity in goats vaccinated with a pureE deletion mutant or the parental 16M strain of Brucella melitensis. Infect. Immun. 64:2431-2439.
34. Chirhart-Gilleland, R. L., M. E. Kovach, P. H. Elzer, S. R. Jennings, and R. M. Roop, 2nd. 1998. Identification and characterization of a 14-kilodalton Brucella abortus protein reactive with antibodies from naturally and experimentally infected hosts and T lymphocytes from experimentally infected BALB/c mice. Infect. Immun. 66:4000-4003.
35. Comerci, D. J., M. J. Martinez-Lorenzo, R. Sieira, J. P. Gorvel, and R. A. Ugalde. 2001. Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell. Microbiol. 3:159-168.
36. Contag, C. H., P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, and D. A. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603.
37. Corbeil, L. B., K. Blau, T. J. Inzana, K. H. Nielsen, R. H. Jacobson, R. R. Corbeil, and A. J. Winter. 1988. Killing of Brucella abortus by bovine serum. Infect. Immun. 56:3251-3261.
38. Corbel, M. J. 1990. Brucella, p. 339-353. In M. T. Parker and L. H. Collier (ed.), Topley and Wilson's principles of bacteriology, virology and immunology, 8th ed. Edward Arnold, London, England.
39. Corbel, M. J. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
40. Cossart, P., P. Boquet, S. Normark, and R. Rappuoli. 1996. Cellular microbiology emerging. Science 271:315-316.
41. Crawford, R. M., D. V. Van, L. Yuan, T. L. Hadfield, R. L. Warren, E. S. Drazek, H. H. Houng, C. Hammack, K. Sasala, T. Polsinelli, et al. 1996. Deletion of purE attenuates Brucella melitensis infection in mice. Infect. Immun. 64:2188-2192.
42. Debbarh, H. S., M. S. Zygmunt, G. Dubray, and A. Cloeckaert. 1996. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep. Vet. Microbiol. 53:325-337.
43. Delrue, R. M., M. Martinez-Lorenzo, P. Lestrate, I. Danese, V. Bielarz, P. Mertens, X. De Bolle, A. Tibor, J. P. Gorvel, and J. J. Letesson. 2001. Identification of Brucella spp. genes involved in intracellular trafficking. Cell. Microbiol. 3:487-497.
44. DelVecchio, V. G., V. Kapatral, R. J. Redkar, G. Patra, C. Mujer, T. Los, N. Ivanova, I. Anderson, A. Bhattacharyya, A. Lykidis, G. Reznik, L. Jablonski, N. Larsen, M. D'Souza, A. Bernal, M. Mazur, E. Goltsman, E. Selkoy, P. H. Elzer, S. Hagius, D. O'Callaghan, J. J. Letesson, R. Haselkorn, N. Kyrpides, and R. Overbeek. 2002. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. USA 99:443-448.
45. Denoel, P. A., T. K. Vo, A. Tibor, V. E. Weynants, J. M. Trunde, G. Dubraym, J. N. Limet, and J. J. Letesson. 1997. Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle. Infect. Immun. 65:495-502.
46. Denoel, P. A., T. K. Vo, V. E. Weynants, A. Tibor, D. Gilson, M. S. Zygmunt, J. N. Limet, and J. J. Letesson. 1997. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J. Med. Microbiol. 46:801-806.
47. Detilleux, P. G., B. L. Deyoe, and N. F. Cheville. 1990. Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro. Infect. Immun. 58:2320-2328.
48. Doyle, A. G., W. J. Halliday, C. J. Barnett, T. L. Dunn, and D. A. Hume. 1992. Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Infect. Immun. 60:1465-1472.
49. Drazek, E. S., H. S. Houng, R. M. Crawford, T. L. Hadfield, D. L. Hoover, and R. L. Warren. 1995. Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages. Infect. Immun. 63:3297-3301.
50. Edmonds, M., N. Booth, S. Hagius, J. Walker, F. Enright, and R. M. Roop, Jr., and P. Elzer. 2000. Attenuation and immunogenicity of a Brucella abortus htrA cycL double mutant in cattle. Vet. Microbiol. 76:81-90.
51. Ekaza, E., L. Guilloteau, J. Teyssier, J. P. Liautard, and S. Kohler. 2000. Functional analysis of the ClpATPase ClpA of Brucella suis, and persistence of a knockout mutant in BALB/c mice. Microbiology 146:1605-1616.
52. Elzer, P. H, R. H. Jacobson, K. H. Nielsen, J. T. Douglas, and A. J. Winter. 1994. BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes. Immunol. Lett. 42:145-150.
53. Elzer, P. H., R. W. Phillips, G. T. Robertson, and R. M. Roop, Jr. 1996. The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes. Infect. Immun. 64:4838-4841.
54. Endley, S., D. McMurray, and T. A. Ficht. 2001. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. J. Bacteriol. 183:2454-2462.
55. Fernandes, D. M., R. Benson, and C. L. Baldwin. 1995. Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice. Infect. Immun. 63:4029-4033.
56. Fernandez-Prada, C. M., M. Nikolich, R. Vemulapalli, N. Sriranganathan, S. M. Boyle, G. G. Schurig, T. L. Hadfield, and D. L. Hoover. 2001. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect. Immun. 69:4407-4416.
57. Finlay, B. B., and S. Falkow. 1989. Common themes in microbial pathogenicity. Microbiol. Rev. 53:210-230.
58. Finlay, B. B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169.
59. Foulongne, V., G. Bourg, C. Cazevieille, S. Michaux-Charachon, D. O'Callaghan. 2000. Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis. Infect. Immun. 68:1297-1303.
60. Foulongne, V., K. Walravens, G. Bourg, M. L. Boschiroli, J. Godfroid, M. Ramuz, and D. O'Callaghan. 2001. Aromatic compound-dependent Brucella suis is attenuated in both cultured cells and mouse models. Infect. Immun. 69:547-550.
61. Francis, K. P., D. Joh, C. Bellinger-Kawahara, M. J. Hawkinson, T. F. Purchio, and P. R. Contag. 2000. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 68:3594-3600.
62. Frenchick, P. J., R. J. Markham, and A. H. Cochrane. 1985. Inhibition of phagosome-lysosome fusion in macrophages by soluble extracts of virulent Brucella abortus. Am. J. Vet. Res. 46:332-335.
63. Fridovich, I. 1989. Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 264:7761-7764.
64. Gay, B., S. Sanchez-Teff, and R. Caravano. 1984. Ultrastructural localization of NADPH-oxidase activity in murine peritoneal macrophages during phagocytosis of Brucella. Correlation with the production of superoxide anions. Virchows. Arch. B 45:147-155.
65. Godfroid, F, B. Taminiau, I. Danese. P. Denoel, A. Tibor, V. Weynants, A. Cloeckaert, J. Godfroid, and J. J. Letesson. 1998. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. Infect. Immun. 66:5485-5493.
66. Goldbaum, F. A., J. Leoni, J. C. Wallach, and C. A. Fossati. 1993. Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J. Clin. Microbiol. 31:2141-2145.
67. Goldbaum, F. A., C. A. Velikovsky, P. C. Baldi, S. Mortl, A. Bacher, and C. A. Fossati. 1999. The 18-kDa cytoplasmic protein of Brucella species - an antigen useful for diagnosis - is a lumazine synthase. J. Med. Microbiol. 48:833-839.
68. Grillo, M. J., N. Bosseray, and J. M. Blasco. 2000. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines. Biologicals 28:119-127.
69. Halling, S. M., P. G. Detilleux, F. M. Tatum, B. A. Judge, and J. E. Mayfield. 1991. Deletion of the BCSP31 gene of Brucella abortus by replacement. Infect. Immun. 59:3863-3868.
70. Hemmen, F., V. Weynants, T. Scarcez, J. J. Letesson, and E. Saman. 1995. Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin. Diagn. Lab. Immunol. 2:263-267.
71. Ho, M., and C. Cheers. 1982. Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus. J. Infect. Dis. 146:381-387.
72. Hoffmann, E. M., and J. J. Houle. 1983. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement. Vet. Immunol. Immunopathol. 5:65-76.
73. Hoffmann, E. M., and J. J. Houle. 1995. Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host. Crit. Rev. Microbiol. 21:153-163.
74. Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
75. Hong, P. C., R. M. Tsolis, and T. A. Ficht. 2000. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68:4102-4107.
76. Hoover, D. L., R. M. Crawford, L. L. Van De Verg, M. J. Izadjoo, A. K. Bhattacharjee, C. M. Paranavitana, R. L. Warren, M. P. Nikolich, and T. L. Hadfield. 1999. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16M ΔpurEK). Infect. Immun. 67:5877-5884.
77. Inon de Iannino, N., G. Briones, M. Tolmasky, and R. A. Ugalde. 1998. Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1-2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants. J. Bacteriol. 180:4392-4400.
78. Ireton, K., B. Payrastre, H. Chap, W. Ogawa, H. Sakaue, M. Kasuga, and P. Cossart. 1996. A role for phosphoinositide 3-kinase in bacterial invasion. Science 274:780-782.
79. Izadjoo, M. J., Y. Polotsky, M. G. Mense, A. K. Bhattacharjee, C. M. Paranavitana, T. L. Hadfield, and D. L. Hoover. 2000. Impaired control of Brucella melitensis infection in Rag1-deficient mice. Infect. Immun. 68:5314-5320.
80. Jahans, K. L., G. Foster, and E. S. Broughton. 1997. The characterisation of Brucella strains isolated from marine mammals. Vet. Microbiol. 57:373-382.
81. Jiang, X., and C. L. Baldwin. 1993. Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon-gamma. Cell. Immunol. 148:397-407.
82. Jiang, X., B. Leonard, R. Benson, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319.
83. Jimenez de Bagues, M. P., C. M. Marin, M. Barberan, and J. M. Blasco. 1989. Responses of ewes to B. melitensis Rev1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy. Ann. Rech. Vet. 20:205-213.
84. Jimenez de Bagues, M. P., M. Barberan, C. M. Marin, and J. M. Blasco. 1995. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine 13:301-304.
85. Jones, S. M., and A. J. Winter. 1992. Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect. Immun. 60:3011-3014.
86. Kaufmann, A. F., M. I. Meltzer, and G. P. Schmid. 1997. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg. Infect. Dis. 3:83-94.
87. Keleti, G., D. S. Feingold, and J. S. Youngner. 1974. Interferon induction in mice by lipopolysaccharide from Brucella abortus. Infect. Immun. 10:282-283.
88. Kittelberger, R., F. Hilbink, M. F. Hansen, G. P. Ross, G. W. de Lisle, A. Cloeckaert, and J. de Bruyn. 1995. Identification and characterization of immunodominant antigens during the course of infection with Brucella ovis. J. Vet. Diagn. Investig. 7:210-218.
89. Ko, J., A. Gendron-Fitzpatrick, and G. A. Splitter. 2002. Susceptibility of interferon regulatory factor (IRF-1) and interferon consensus sequence binding protein (ICSBP) deficient mice to brucellosis. J. Immunol. 168:2433-2440.
90. Ko, J., A. Gendron-Fitzpatrick, T. A. Ficht, and G. A. Splitter. 2002. Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor-1 deficient mice. Infect. Immun. 70:7004-7012.
91. Kohler, S., M. Layssac, A. Naroeni, I. Gentschev, M. Rittig, and J. P. Liautard. 2001. Secretion of listeriolysin by Brucella suis inhibits its intramacrophagic replication. Infect. Immun. 69:2753-2756.
92. Kohler, S., S. Ouahrani-Bettache, M. Layssac, J. Teyssier, and J. P. Liautard. 1999. Constitutive and inducible expression of green fluorescent protein in Brucella suis. Infect. Immun. 67:6695-6697.
93. Kohler, S., J. Teyssier, A. Cloeckaert, B. Rouot, and J. P. Liautard. 1996. Participation of the molecular chaperone DnaK in intracellular growth of Brucella suis within U937-derived phagocytes. Mol. Microbiol. 20:701-712.
94. Kovach, M. E., P. H. Elzer, G. T. Robertson, R. L. Chirhart-Gilleland, M. A. Christensen, K. M. Peterson, and R. M. Roop, Jr. 1997. Cloning and nucleotide sequence analysis of a Brucella abortus gene encoding an 18 kDa immunoreactive protein. Microb. Pathog. 22:241-246.
95. Kreutzer, D. L., L. A. Dreyfus, and D. C. Robertson. 1979. Interaction of polymorphonuclear leukocytes with smooth and rough strains of Brucella abortus. Infect. Immun. 23:737-742.
96. Kurar, E., and G. A. Splitter. 1997. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 15:1851-1857.
97. Lestrate, P., R. M. Delrue, I. Danese, C. Didembourg, B. Taminiau, P. Mertens, X. De Bolle, A. Tibor, C. M. Tang, and J. J. Letesson. 2000. Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol. Microbiol. 38:543-551.
98. LeVier, K., R. W. Phillips, V. K. Grippe, R. M. Roop, Jr., and G. C. Walker. 2000. Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival. Science 287:2492-2493.
99. Liautard, J. P., A. Gross, J. Dornand, and S. Kohler. 1996. Interactions between professional phagocytes and Brucella spp. Microbiologia 12:197-206.
100. Limet, J. N., A. Cloeckaert, G. Bezard, J. Van Broeck. and G. Dubray. 1993. Antibody response to the 89-kDa outer membrane protein of Brucella in bovine brucellosis. J. Med. Microbiol. 39:403-407.
101. Lin, J., and T. A. Ficht. 1995. Protein synthesis in Brucella abortus induced during macrophage infection. Infect. Immun. 63:1409-1414.
102. Lindler, L. E., T. L. Hadfield, B. D. Tall, N. J. Snellings, F. A. Rubin, L. L. Van De Verg, D. Hoover, and R. L. Warren. 1996. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect. Immun. 64:2490-2499.
103. Madkour, M. M. 2001. Madkour's brucellosis, p. 11. Springer Verlag, New York, N.Y.
104. McQuiston, J. R., R. Vemulapalli, T. J. Inzana, G. G. Schurig, N. Sriranganathan, D. Fritzinger, T. L. Hadfield, R. A. Warren, L. E. Lindler, N. Snellings, et al. 1999. Genetic characterization of a Tn 5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect. Immun. 67:3830-3835.
105. Michaux, S., J. Paillisson, M. J. Carles-Nurit, G. Bourg, A. Allardet-Servent, and M. Ramuz. 1993. Presence of two independent chromosomes in the Brucella melitensis 16M genome. J. Bacteriol. 175:701-705.
106. Michaux-Charachon, S., G. Bourg, E. Jumas-Bilak, P. Guigue-Talet, A. Allardet-Servent, D. O'Callaghan, and M. Ramuz. 1997. Genome structure and phylogeny in the genus Brucella. J. Bacteriol. 179:3244-3249.
107. Montaraz, J. A., and A. J. Winter. 1986. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:245-251.
108. Montaraz, J. A., A. J. Winter, D. M. Hunter, B. A. Sowa, A. M. Wu, and L. G. Adams. 1986. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect. Immun. 51:961-963.
109. Moreno, E., E. Stackebrandt, M. Dorsch, J. Wolters, M. Busch, and H. Mayer. 1990. Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J. Bacteriol. 172:3569-3576.
110. Reference deleted.
111. Mounier, J., V. Laurent, A. Hall, P. Fort, M. F. Carlier, P. J. Sansonetti, and C. Egile. 1999. Rho family GTPases control entry of Shigella flexneri into epithelial cells but not intracellular motility. J. Cell Sci. 112:2069-2080.
112. Muffler, A., D. Fischer, and R. Hengge-Aronis. 1996. The RNA-binding protein HF-I, known as a host factor for phage Qβ RNA replication, is essential for rpoS translation in Escherichia coli. Genes Dev. 10:1143-1151.
113. Murphy, E. A, J. Sathiyaseelan, M. A. Parent, B. Zou, and C. L. Baldwin. 2001. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103:511-518.
114. Naroeni, A., N. Jouy, S. Ouahrani-Bettache, J. P. Liautard, and F. Porte. 2001. Brucella suis-impaired specific recognition of phagosomes by lysosomes due to phagosomal membrane modifications. Infect. Immun. 69:486-493.
115. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841-8848.
116. O'Callaghan, D., C. Cazevieille, A. Allardet-Servent, M. L. Boschiroli, G. Bourg, V. Foulongne, P. Frutos, Y. Kulakov, and M. Ramuz. 1999. A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Pt1 type IV secretion systems is essential for intracellular survival of Brucella suis. Mol. Microbiol. 33:1210-1220.
117. Oliveira, S. C., J. S. Harms, M. Banai, and G. A. Splitter. 1996. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell. Immunol. 172:262-268.
118. Oliveira, S. C., and G. A. Splitter. 1994. Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect. Immun. 62:5201-5204.
119. T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur. J. Immunol. 25:2551-2557.
120. Oliveira, S. C., and G. A. Splitter. 1996. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14:959-962.
121. Olsen, S. C., N. F. Cheville, M. G. Stevens, H. H. Houng, E. S. Drazek, T. L. Hadfield, R. L. Warren, and D. L. Hoover. 1997. Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a purE201 strain. Infect. Immun. 65:2987-2991.
122. Ottones, F., J. Dornand, A. Naroeni, J. P. Liautard, and J. Favero. 2000. Vγ9Vδ2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J. Immunol. 165:7133-7139.
123. Ottones, F., J. Liautard, A. Gross, F. Rabenoelina, J. P. Liautard, and J. Favero. 2000. Activation of human Vγ9Vδ2 T cells by a Brucella suis non-peptidic fraction impairs bacterial intracellular multiplication in monocytic infected cells. Immunology 100:252-258.
124. Pavlov, H., M. Hogarth, I. F. McKenzie, and C. Cheers. 1982. In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell. Immunol. 71:127-138.
125. Phillips, M., B. L. Deyoe, and P. C. Canning. 1989. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen. Am. J. Vet. Res. 50:2158-2161.
126. Phillips, R. W., P. H. Elzer, G. T. Robertson, S. D. Hagius, J. V. Walker, M. B. Fatemi, F. M. Enright, and R. M. Roop, Jr. 1997. A Brucella melitensis high-temperature-requirement A (htrA) deletion mutant is attenuated in goats and protects against abortion. Res. Vet. Sci. 63:165-167.
127. Pizarro-Cerda, J., M. Desjardins, E. Moreno, S. Akira, and J. P. Gorvel. 1999. Modulation of endocytosis in nuclear factor IL-6(-/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection. J. Immunol. 162:3519-3526.
128. Pizarro-Cerda, J., S. Meresse, R. G. Parton, G. van der Goot, A. SolaLanda, I. Lopez-Goni, E. Moreno, and J. P. Gorvel. 1998. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect. Immun. 66:5711-5724.
129. Pizarro-Cerda, J., E. Moreno, M. Desjardins, and J. P. Gorvel. 1997. When intracellular pathogens invade the frontiers of cell biology and immunology. Histol. Histopathol. 12:1027-1038.
130. Porte, F., J. P. Liautard, and S. Kohler. 1999. Early acidification of phagosomes containing Brucella suis is essential for intracellular survival in murine macrophages. Infect. Immun. 67:4041-4047.
131. Price, R. E., J. W. Templeton, and L. G. Adams. 1990. Survival of smooth, rough and transposon mutant strains of Brucella abortus in bovine mammary macrophages. Vet. Immunol. Immunopathol. 26:353-365.
132. Rafie-Kolpin, M., R. C. Essenberg, and J. H. Wyckoff III. 1996. Identification and comparison of macrophage-induced proteins and proteins induced under various stress conditions in Brucella abortus. Infect. Immun. 64:5274-5283.
133. Riley, L. K., and D. C. Robertson. 1984. Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes. Infect. Immun. 46:224-230.
134. Rittig, M. G., M. T. Alvarez-Martinez, F. Porte, J. P. Liautard, and B. Rouot. 2001. Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes. Infect. Immun. 69:3995-4006.
135. Robertson, G. T., M. E. Kovach, C. A. Allen, T. A. Ficht, and R. M. Roop, Jr. 2000. The Brucella abortus Lon functions as a generalized stress response protease and is required for wild-type virulence in BALB/c mice. Mol. Microbiol. 35:577-588.
136. Robertson, G. T., and R. M. Roop, Jr. 1999. The Brucella abortus host factor I (HF-I) protein contributes to stress resistance during stationary phase and is a major determinant of virulence in mice. Mol. Microbiol. 34:690-700.
137. Robertson, M. 1998. Innate immunity: Curr. Biol. 8:R595-R597.
138. Roop, R. M., Jr., T. W. Fletcher, N. M. Sriranganathan, S. M. Boyle, and G. G. Schurig. 1994. Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect. Immun. 62:1000-1007.
139. Roop, R. M., Jr., R. W. Phillips, S. Hagius, J. V. Walker, N. J. Booth, W. Todd Fulton, M. D. Edmonds, and P. H. Elzer. 2001. Re-examination of the role of the Brucella melitensis HtrA stress response protease in virulence in pregnant goats. Vet. Microbiol. 82:91-95.
140. Rossetti, O. L., A. I. Arese, M. L. Boschiroli, and S. L. Cravero. 1996. Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. J. Clin. Microbiol. 34:165-169.
141. Salmeron, I., M. Rodriguez-Zapata, O. Salmeron, L. Manzano, S. Vaquer, and M. Alvarez-Mon. 1992. Impaired activity of natural killer cells in patients with acute brucellosis. Clin. Infect. Dis. 15:764-770.
142. Sanchez, D. O., R. O. Zandomeni, S. Cravero, R. E. Verdun, E. Pierrou, P. Faccio, G. Diaz, S. Lanzavecchia, F. Aguero, A. C. Frasch, et al. 2001. Gene discovery through genomic sequencing of Brucella abortus. Infect. Immun. 69:865-868.
143. Sangari, F. J., and J. Aguero. 1996. Molecular basis of Brucella pathogenicity: an update. Microbiologia 12:207-218.
144. Saunders, B. M., Z. Liu, Y. Zhan, and C. Cheers. 1993. Interleukin-6 production during chronic experimental infection. Immunol. Cell. Biol. 71:275-280.
145. Schurig, G. G., R. M. Roop, Jr., T. Bagchi, S. Boyle, D. Buhrman, and N. Sriranganathan. 1991. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28:171-188.
146. Sieira, R., D. J. Comerci, D. O. Sanchez, and R. A. Ugalde. 2000. A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication. J. Bacteriol. 182:4849-4855.
147. Sola-Landa, A., J. Pizarro-Cerda, M. J. Grillo, E. Moreno, I. Moriyon, J. M. Blasco, J. P. Gorvel, and I. Lopez-Goni. 1998. A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence Mol. Microbiol. 29:125-138.
148. Stemshorn, B., K. Nielsen, and B. Samagh. 1981. The bovine immune response to Brucella abortus. III. Preparation of antisera against a Brucella component precipitated by sera of some infected cattle. Can. J. Comp. Med. 45:77-81.
149. Stevens, M. G., S. C. Olsen, G. W. Pugh, Jr., and D. Brees. 1995. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect. Immun. 63:264-270.
150. Stevens, M. G., S. C. Olsen, G. W. Pugh, and J. E. Mayfield. 1997. Role of immune responses to a GroEL heat shock protein in preventing brucellosis in mice vaccinated with Brucella abortus strain RB51. Comp. Immunol. Microbiol. Infect. Dis. 20:147-153.
151. Stevens, M. G., S. C. Olsen, G. W. Pugh, Jr., and M. V. Palmer. 1994. Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308. Infect. Immun. 62:3206-3212.
152. Stevens, M. G., L. B. Tabatabai, S. C. Olsen, and N. F. Cheville. 1994. Immune responses to superoxide dismutase and synthetic peptides of superoxide dismutase in cattle vaccinated with Brucella abortus strain 19 or RB51. Vet. Microbiol. 41:383-389.
153. Tabatabai, L. B., and G. W. Pugh, Jr. 1994. Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine 12:919-924.
154. Tatum, F. M., P. G. Detilleux, J. M. Sacks, and S. M. Halling. 1992. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect. Immun. 60:2863-2869.
155. Teixeira-Gomes, A. P., A. Cloeckaert, G. Bezard, R. A. Bowden, G. Dubray, and M. S. Zygmunt. 1997. Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting. Electrophoresis 18:1491-1497.
156. Ugalde, J. E., C. Czibener, M. F. Feldman, and R. A. Ugalde. 2000. Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication. Infect. Immun. 68:5716-5723.
157. Van, M. D., G. A. Kennedy, S. C. Olsen, G. R. Hansen, and D. R. Ewalt. 1999. Brucellosis induced by RB51 vaccine in a pregnant heifer. J. Am. Vet. Med. Assoc. 215:1491-1493, 1449.
158. Vemulapalli, R., A. J. Duncan, S. M. Boyle, N. Sriranganathan, T. E. Toth, and G. G. Schurig. 1998. Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect. Immun. 66:5684-5691.
159. Vizcaino, N., A. Cloeckaert, G. Dubray, and M. S. Zygmunt. 1996. Cloning, nucleotide sequence, and expression of the gene coding for a ribosome releasing factor-homologous protein of Brucella melitensis. Infect. Immun. 64:4834-4837.
160. Vizcaino, N., M. S. Zygmunt, J. M. Verger, M. Grayon, and A. Cloeckaert. 1997. Localization and characterization of a specific linear epitope of the Brucella DnaK protein. FEMS Microbiol. Lett. 154:117-122.
161. Winter, A. J., J. R. Duncan, C. G. Santisteban, J. T. Douglas, and L. G. Adams. 1989. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice. Infect. Immun. 57:3438-3444.
162. Winter, A. J., G. G. Schurig, S. M. Boyle, N. Sriranganathan, J. A. Bevins, F. M. Enright, P. H. Elzer, and J. D. Kopec. 1996. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am. J. Vet. Res. 57:677-683.
163. Yabu, K., J. S. Youngner, D. S. Feingold, G. Keleti, and E. Gorelik. 1991. Augmentation of natural killer cell activity in mice by Bru-Pel. J. Immunother. 10:307-312.
164. Young, E. J., M. Borchert, F. L. Kretzer, and D. M. Musher. 1985. Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes. J. Infect. Dis. 151:682-690.
165. Zaitseva, M., H. Golding, J. Manischewitz, D. Webb, and B. Golding. 1996. Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus. Infect. Immun. 64:3109-3117.
166. Zhan, Y., and C. Cheers. 1993. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61:4899-4901.
167. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390.
168. Zhan, Y., and C. Cheers. 1998. Control of IL-12 and IFN-γ production in response to live or dead bacteria by TNF and other factors. J. Immunol. 161:1447-1453.
169. Zhan, Y., A. Kelso, and C. Cheers. 1993. Cytokine production in the murine response to Brucella infection or immunization with antigenic extracts. Immunology 80:458-464.
170. Zhan, Y., Z. Liu, and C. Cheers. 1996. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 64:2782-2786.
171. Zhan, Y. F., E. R. Stanley, and C. Cheers. 1991. Prophylaxis or treatment of experimental brucellosis with interleukin-1. Infect. Immun. 59:1790-1794.
172. Zhu, Y., S. C. Oliveira, and G. A. Splitter. 1993. Isolation of Brucella abortus ssb and uvrA genes from a genomic library by use of lymphocytes as probes. Infect. Immun. 61:5339-5344.
173. Zygmunt, M. S., F. B. Gilbert, and G. Dubray. 1992. Purification, characterization, and seroactivity of a 20-kilodalton Brucella protein antigen. J. Clin. Microbiol. 30:2662-2667.